Abstract
Tricyclic antidepressant drugs reduce the sensitivity of α2 adrenoceptors during long-term treatment. In the present study, the α2 adrenergic agonist clonidine was administered to 11 depressed patients before and during treatment with the triazolopyridine antidepressant trazodone (TRZ). Clonidine's ability to decrease blood pressure (BP) and plasma levels of the norepinephrine metabolite 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG), and to increase sedation and plasma growth hormone (GH), were measured. TRZ had little effect on these indices of pre- and postsynaptic α2 receptor function, suggesting that the antidepressant properties of TRZ are not related to changes in α2 adrenoceptor sensitivity.
Similar content being viewed by others
References
Al-Yassiri MM, Ankier SI, Bridges PK (1981) Minireview. Trazodone — A new antidepressant. Life Sci 28:2449–2458
Anden NE, Grobowski M, Strombom U (1976) Different alpha-adrenoceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents. Naunyn-Schmiedberg's Arch Pharmacol 292:43–52
Baran L, Maj J, Rogoz Z, Skuza G (1979) On the central antiserotonin action of trazodone. Pol J Pharmacol Pharm 31:25–33
Blombery P, Kopin IJ, Gordon EK, Markey SP, Ebert M (1980) Conversion of MHPG to vanillylmandelic acid: Implications for the importance of urinary MHPG. Arch Gen Psychiatry 37:1095–1098
Bousquet P, Schwartz J (1983) Alpha-adrenergic drugs: Pharmacological tools for the study of the central vasomotor control. Biochem Pharmacol 32(9):1459–1465
Brogden RN, Heel RC, Speight TM, Avery GS (1981) Trazodone: A review of its pharmacological properties and therapeutic use in depression and anxiety. Drugs 21:401–429
Cedarbaum JM, Aghajanian GK (1977) Catecholamine receptors on locus coeruleus neurons: Pharmacological characterization. Eur J Pharmacol 44:375–385
Cella SG, Picotti GB, Muller EE (1983) α2-Adrenergic stimulation enhances growth hormone secretion in the dog: A presynaptic mechanism? Life Sci 32:2785–2792
Cervo L, Ballabio M, Caccia S, Samanin R (1981) Blockade by trazodone of naloxone-precipitated jumping in morphine-dependent rats: Correlation with brain levels of m-chlorophenyl-piperazine. J Pharm Pharmacol 33:813–814
Charney DS, Heninger GR, Sternberg DE, Hafstad KM, Giddings S, Landis DH (1982a) Adrenergic receptor sensitivity in depression: Effects of clonidine in depressed patients and healthy subjects. Arch Gen Psychiatry 39:290–294
Charney DS, Heninger GR, Sternberg DE (1982b) Failure of chronic antidepressant treatment to alter growth hormone response to clonidine. Psychiatr Res 7:135–138
Charney DS, Heninger GR, Sternberg GR (1982c) Assessment of alpha-2 adrenergic autoreceptor function in humans: Effects of oral yohimbine. Life Sci 30:2033–2041
Charney DS, Heninger GR, Sternberg DE (1983) Alpha-2 adrenergic receptor sensitivity and the mechanism of action of antidepressant therapy: The effect of long-term amitriptyline treatment. Br J Psychiatry 142:265–275
Charney DS, Heninger GR, Sternberg DE (1984) The effect of mianserin on alpha-2 adrenergic receptor function in depressed patients. Br J Psychiatry 144:407–416
Charney DS, Menkes DB, Heninger GR (1981a) Receptor sensitivity and the mechanism of action of antidepressant treatment: Implications for the etiology and therapy of depression. Arch Gen Psychiatry 38:1160–1180
Charney DS, Heninger GR, Sternberg DE, Redmond DE Jr, Leckman JF, Maas JW, Roth RH (1981b) Presynaptic adrenergic receptor sensitivity in depression: The effect of long-term desipramine treatment. Arch Gen Psychiatry 38:1334–1340
Checkley SA, Slade AP, Shur E, Dawling S (1981a) Growth hormone and other responses to clonidine in patients with endogenous depression. Br J Psychiatry 138:51–55
Checkley SA, Slade AP, Shur E, Dawling S (1981b) A pilot study of the mechanism of action of desipramine. Br J Psychiatry 138:248–251
Chesselet M-F (1984) Presynaptic regulation of neurotransmitter release in the brain: Facts and hypothesis. Neuroscience 12(2):347–375
Cioli V, Corradino C, Piccinelli D, Rocchi MG, Valeri R (1984) A comparative pharmacological study of trazodone, etoperidone and 1-(m-chlorophenyl)piperazine. Pharmacol Res Commun 16(1):85–100
Clements-Jewery S (1978) The development of cortical β-adrenoceptor subsensitivity in the rat by chronic treatment with trazodone, doxepin and mianserine. Neuropharmacology 17:779–781
Clements-Jewery S, Robson PA, Chidley LJ (1980) Biochemical investigations into the mode of action of trazodone. Neuropharmacology 19:1165–1173
Cooper JR, Bloom FE, Roth RH (1982) The biochemical basis of neuropharmacology, 4th ed., New York, Oxford University Press
Corn TH, Thompson C, Checkley SA (1984) Effects of desipramine treatment upon central adrenoceptor function in normal subjects. Br J Psychiatry 145:139–145
Dekirmenjian H, Maas JW (1974) 3-Methoxy-4-hydroxyphenylethyleneglycol in plasma. Clin Chim Acta 52:203–210
Dixon WJ, Massey FJ Jr (1969) Introduction to statistical analysis. New York, McGraw-Hill
Dowdall M, deMontigny C (1984) Pre- and postsynaptic effects of trazodone on serotonin neurotransmission: Single-cell studies in the rat. Abstr Soc Neurosci 10(1):17
Elsworth JD, Redmond DE, Roth RH (1982) Plasma and cerebrospinal fluid 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) as indices of brain norepinephrine metabolism in primates. Brain Res 235:115–124
Enna SJ, Kendall DA (1981) Interaction of antidepressants with brain neurotransmitter receptors. J Clin Psychopharmacol, 1 [Suppl]:12S-16S
Faroum F, Mayer-Schwing J, Potkin SG, Wyatt RJ (1977) Presence of free sulfate and glucuronide conjugated MHPG in human brain, cerebrospinal fluid, and plasma. Brain Res 125:333–339
Fuller RW, Snoddy HD, Cohen ML (1984) Interactions of trazodone with serotonin neurons and receptors. Neuropharmacology 23(5):539–544
Glass IB, Checkley SA, Shur E, Dawling S (1982) The effect of desipramine on central adrenergic function in depressed patients. Br J Psychiatry 141:372–376
Gundert-Remy U, Aman E, Hildebrandt R, Weber E (1983) Lack of interaction between the tetracyclic antidepressant maprotiline and the centrally acting antihypertensive drug clonidine. Eur J Clin Pharmacol 25(5):595–599
Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62
Healy D, Carney PA, Leonard BE (1982) Monoamine-related markers of depression: Changes following treatment. J Psychiatr Res 17(3):251–260
Healy D, Carney PA, Leonard BE (1984) Biochemical correlates of antidepressant response: Results of a trazodone versus amitriptyline trial. Psychopathology 17 [Suppl 2]:82–87
Hingtgen JN, Hendrie HC, Aprison MH (1984) Postsynaptic serotonergic blockade following chronic antidepressive treatment with trazodone in an animal model of depression. Pharmacol Biochem Behav 20:425–428
Jimerson DC, Ballenger JD, Lake CR, Post RM, Goodwin FK, Kopin IJ (1981) Plasma and CSF MHPG in normals. Psychopharmacol Bull 17:86–87
Koe BK (1976) Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J Pharmacol Exp Ther 199:649–661
Kopin IJ, Jimerson DC, Markey SP, Ebert MH, Polinsky RJ (1984) Disposition and metabolism of MHPG in humans: Application to studies in depression. Pharmacopsychiatry 17:3–8
Larochelle P, Hamet P, Enjalbert M (1979) Responses to tyramine and norepinephrine after imipramine and trazodone. Clin Pharmacol Ther 26(1):24–30
Leckman JF, Maas JW, Heninger GR (1981) Covariance of plasma free 3-methoxy-4-hydroxyphenylethyleneglycol and diastolic blood pressure. Eur J Pharmacol 70:111–120
Leckman JF, Maas JW (1984) Plasma MHPG: Relationship to brain noradrenergic systems and emerging clinical applications. In: Post RM, Ballenger JC (eds) Neurobiology of mood disorders. Baltimore, Williams & Wilkins, pp 529–538
Leckman JF, Maas JW, Redmond DE Jr, Heninger GR (1980) Effects of oral clonidine on plasma 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG) in man: Preliminary report. Life Sci 26:2179–2185
Maas JW, Hattox SE, Landis DH, Roth RH (1976) The determination of a brain arteriovenous difference for 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG). Brain Res 118:167–173
Maggi A, U'Prichard DC, Enna SJ (1980) Differential effects of antidepressant treatment on brain monoaminergic receptors. Eur J Pharmacol 61:91–98
Maj J, Palider W, Rawlow A (1979) Trazodone, a central serotonin antagonist and agonist. J Neural Transm 44:237–248
Matussek N, Ackenheil M, Hippius H, Muller F, Shroder H-Th, Schultes H, Wasilewski B (1980) Effects of clonidine on growth hormone release in psychiatric patients and controls. Psychiatr Res 2:25–36
McWilliam JR, Meldrum BS (1983) Noradrenergic regulation of growth hormone secretion in the baboon. Endocrinology 112:234–239
Nassif S, Kempf E, Cardo B, Velley L (1983) Neurochemical lesion of the locus coeruleus of the rat does not suppress the sedative effect of clonidine. Eur J Pharmacol 91:69–76
Passarelli F, Scotti DeCarolis A (1983) Effects of chronic treatment with imipramine, trazodone and electroshock on the behavioural and electroencephalographic modifications induced by clonidine in the rat. Neuropharmacology 22(6):785–789
Peterson SL, Napier TC, Rigdon GC, Pirch JH (1983) Dissimilar responses of cortical neurons to chronic trazodone or desipramine treatment. Prog Neuro-Psychopharmacol Biol Psychiatry 7:175–181
Riblet IA, Gatewood CF, Mayol RF (1979) Comparative effects of trazodone and tricyclic antidepressants on uptake of selected neurotransmitters by isolated rat brain synaptosomes. Psychopharmacology 63:99–101
Riblet LA, Taylor DP (1981) Pharmacology and neurochemistry of trazodone. J Clin Psychopharmacol 1 [Suppl]:17–22S
Richardson JS, Chiu EKY (1982) The acute effects of amitriptyline, iprindole and trazodone on blood pressure and heart rate in rats. Pharmacol Biochem Behav 17:1221–1223
Richelson E, Pfenning M (1984) Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: Most antidepressants selectively block norepinephrine uptake. Eur J Pharmacol 104:277–286
Rowbotham MD, Jones RT, Benowitz NL, Jacob P (1984) Trazodone-oral cocaine interactions. Arch Gen Psychiatry 41:895–899
Schalch DS, Parker ML (1964) A sensitive double antibody immunoassay for human growth hormone in plasma. Nature 263:1141–1142
Scuvee-Moreau J, Dresse A (1982) Effect of trazodone on the firing rate of central monoaminergic neurons. Comparison with various antidepressants. Arch Int Pharmacody 260:299–301
Siever LJ, Uhde TW, Insel TR, Roy BF, Murphy DL (1982a) Growth hormone response to clonidine unchanged by chronic clorgyline treatment. Psychiatr Res 7:139–143
Siever LJ, Uhde TW, Murphy DL (1982b) Possible subsensitization of alpha-2 adrenergic receptors by chronic monoamine oxidase inhibitor treatment in psychiatric patients. Psychiatr Res 6:293–302
Siever LJ, Uhde TW, Silberman EK, Jimerson DC, Aloi JA, Post RM, Murphy DL (1982c) The growth hormone response as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls. Psychiatr Res 6:171–183
Stefanini E, Fadda F, Medda L, Gessa GL (1976) Selective inhibition of serotonin uptake by trazodone, a new antidepressant agent. Life Sci 18:1459–1466
Stone EA (1983) Problems with current catecholamine hypotheses of antidepressant agents: Speculations leading to a new hypothesis. Behav Brain Sci 6:535–577
Strombom U, Svensson TH (1980) Clonidine: attenuation of sedative action by facilitated central noradrenergic neurotransmission. J Neural Transm 47:29–39
Sugrue MF (1983a) Chronic antidepressant therapy and associated changes in central monoaminergic receptor functioning. Pharmacol Ther 21:1–33
Sugrue MF (1983b) Some effects of chronic antidepressant treatments on rat brain monoaminergic systems. J Neural Transm 57:281–295
Sulser F (1984) Regulation and function of noradrenaline receptor systems in brain. Neuropharmacology 23 (2B):255–261
Tempesta E, Janiri L, Salera P (1984) The effects of microiontophoretically applied trazodone on single neurones in the rat brain-stem. Drug Res 34(1):157–160
Terry LC, Martin JB (1981) Evidence for alpha-adrenergic regulation of episodic growth hormone and prolactin secretion in the undisturbed male rat. Endocrinology 108:1869–1873
Timmermans PBMWM, Schoop AMC, Kwa HY, van Zwieten PA (1981) Characterization of the alpha-adrenoceptors participating in the central hypotensive and sedative effects of clonidine using yohimbine, rauwolscine, and coryanthine. Eur J Pharmacol 70:7–16
Unnerstall JR, Kopajtic TA, Kuhar MJ (1984) Distribution of α2 agonist binding sites in the rat and human central nervous system: Analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agents. Brain Res Rev 7:69–101
van Zwieten PA (1977) Inhibition of the central hypotensive effect of clonidine by trazodone, a novel antidepressant. Pharmacology 15:331–336
Zavadil AP, Ross RJ, Calil HM, Linnoila M, Blombery P, Jimerson DC, Kopin IJ, Potter WZ (1984) The effect of desmethylimipramine on the metabolism of norepinephrine. Life Sci 35:1061–1068
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Price, L.H., Charney, D.S. & Heninger, G.R. Effects of trazodone treatment on alpha-2 adrenoceptor function in depressed patients. Psychopharmacology 89, 38–44 (1986). https://doi.org/10.1007/BF00175186
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00175186